156 related articles for article (PubMed ID: 32660332)
1. Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Children.
Donaldson AM; Choby G; Kim DH; Marks LA; Lal D
Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1087-1096. PubMed ID: 32660332
[TBL] [Abstract][Full Text] [Related]
2. Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Adults.
Donaldson AM; Choby G; Kim DH; Marks LA; Lal D
Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1097-1108. PubMed ID: 32539494
[TBL] [Abstract][Full Text] [Related]
3. Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta-analysis.
Wu EL; Harris WC; Babcock CM; Alexander BH; Riley CA; McCoul ED
Otolaryngol Head Neck Surg; 2019 Jul; 161(1):18-27. PubMed ID: 30779679
[TBL] [Abstract][Full Text] [Related]
4. Intranasal antihistamine is superior to oral H
Du K; Qing H; Zheng M; Wang X; Zhang L
Ann Allergy Asthma Immunol; 2020 Nov; 125(5):589-596.e3. PubMed ID: 32650045
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic-pituitary-adrenal axis suppression and intranasal corticosteroid use: A systematic review and meta-analysis.
Sampieri G; Namavarian A; Lee JJW; Hamour AF; Lee JM
Int Forum Allergy Rhinol; 2022 Jan; 12(1):11-27. PubMed ID: 34260153
[TBL] [Abstract][Full Text] [Related]
6. A Scholarly Review of the Safety and Efficacy of Intranasal Corticosteroids Preparations in the Treatment of Chronic Rhinosinusitis.
Macias-Valle L; Psaltis AJ
Ear Nose Throat J; 2021 Jun; 100(5):295-301. PubMed ID: 33084428
[TBL] [Abstract][Full Text] [Related]
7. Effects of double-dose intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
Khattiyawittayakun L; Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Snidvongs K
Int Forum Allergy Rhinol; 2019 Jan; 9(1):72-78. PubMed ID: 30179317
[TBL] [Abstract][Full Text] [Related]
8. Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Khattiyawittayakun L; Snidvongs K
Int Forum Allergy Rhinol; 2018 Oct; 8(10):1083-1092. PubMed ID: 29917324
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis.
Valenzuela CV; Liu JC; Vila PM; Simon L; Doering M; Lieu JEC
Laryngoscope; 2019 Jan; 129(1):6-12. PubMed ID: 30229924
[TBL] [Abstract][Full Text] [Related]
10. Effects of decongestant addition to intranasal corticosteroid for chronic rhinitis: a systematic review and meta-analysis.
Khattiyawittayakun L; Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Snidvongs K
Int Forum Allergy Rhinol; 2018 Dec; 8(12):1445-1453. PubMed ID: 30054985
[TBL] [Abstract][Full Text] [Related]
11. Safety of intranasal corticosteroid sprays during pregnancy: an updated review.
Alhussien AH; Alhedaithy RA; Alsaleh SA
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):325-333. PubMed ID: 29164323
[TBL] [Abstract][Full Text] [Related]
12. Safety of intranasal corticosteroids.
Bensch GW
Ann Allergy Asthma Immunol; 2016 Dec; 117(6):601-605. PubMed ID: 27979016
[TBL] [Abstract][Full Text] [Related]
13. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
Lohia S; Schlosser RJ; Soler ZM
Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
[TBL] [Abstract][Full Text] [Related]
14. Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials.
Ahmadi N; Snidvongs K; Kalish L; Sacks R; Tumuluri K; Wilcsek G; Harvey R
Rhinology; 2015 Dec; 53(4):290-302. PubMed ID: 26275683
[TBL] [Abstract][Full Text] [Related]
15. Adverse Events Associated with Intranasal Sprays: An Analysis of the Food and Drug Administration Database and Literature Review.
Ahsanuddin S; Povolotskiy R; Tayyab R; Nasser W; Barinsky GL; Grube JG; Paskhover B
Ann Otol Rhinol Laryngol; 2021 Nov; 130(11):1292-1301. PubMed ID: 33813873
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-Pituitary-Adrenal Axis Pediatric Safety Studies Submitted to the FDA.
Burnham JM; Green DJ; Ray A; Fang S; Yao L; McCune SK; Burckart GJ
Ther Innov Regul Sci; 2021 May; 55(3):622-630. PubMed ID: 33544387
[TBL] [Abstract][Full Text] [Related]
17. Intranasal steroids for acute sinusitis.
Zalmanovici A; Yaphe J
Cochrane Database Syst Rev; 2009 Oct; (4):CD005149. PubMed ID: 19821340
[TBL] [Abstract][Full Text] [Related]
18. Ciclesonide, a hypotonic intranasal corticosteroid.
Neffen H; Wingertzahn MA
Allergy Asthma Proc; 2010; 31 Suppl 1():S29-37. PubMed ID: 20557684
[TBL] [Abstract][Full Text] [Related]
19. Concomitant corticosteroid nasal spray plus antihistamine (oral or local spray) for the symptomatic management of allergic rhinitis.
Feng S; Fan Y; Liang Z; Ma R; Cao W
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3477-3486. PubMed ID: 26545381
[TBL] [Abstract][Full Text] [Related]
20. Intranasal spray medications for maintenance therapy of allergic rhinitis.
Berger WE; Meltzer EO
Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
